BioCardia, Inc.
BCDA
$0.84
-$0.04-4.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 0.00 | 3.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | 0.00 | 3.00K |
| Cost of Revenue | 4.67M | 4.96M | 5.25M | 5.24M | 4.68M |
| Gross Profit | -4.67M | -4.96M | -5.25M | -5.24M | -4.67M |
| SG&A Expenses | 3.15M | 3.32M | 3.34M | 3.61M | 3.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.82M | 8.28M | 8.59M | 8.85M | 8.46M |
| Operating Income | -7.82M | -8.28M | -8.59M | -8.85M | -8.45M |
| Income Before Tax | -7.78M | -8.23M | -8.54M | -8.79M | -8.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.78 | -8.23 | -8.54 | -8.79 | -8.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.78M | -8.23M | -8.54M | -8.79M | -8.39M |
| EBIT | -7.82M | -8.28M | -8.59M | -8.85M | -8.45M |
| EBITDA | -7.80M | -8.25M | -8.55M | -8.81M | -8.39M |
| EPS Basic | -1.04 | -1.41 | -1.73 | -2.10 | -2.58 |
| Normalized Basic EPS | -0.65 | -0.88 | -1.08 | -1.32 | -1.61 |
| EPS Diluted | -1.04 | -1.41 | -1.73 | -2.10 | -2.58 |
| Normalized Diluted EPS | -0.65 | -0.88 | -1.08 | -1.32 | -1.61 |
| Average Basic Shares Outstanding | 32.83M | 26.65M | 20.56M | 17.11M | 13.93M |
| Average Diluted Shares Outstanding | 32.83M | 26.65M | 20.56M | 17.11M | 13.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |